Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell line | Drug name | Experimental replicate | Timepoint | Drug concentration | Live cell count | Average live cell count, DMSO control | Average live cell count (time = 0) | Log10(drug concentration) | GR value | Relative cell count (treatment versus DMSO) | Cell doublings (DMSO control) | Experiment name |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCC70 | PI103 | 1 | 72 | 0.1 | 3244.0 | 3161.3 | 1279.8 | -1.0 | 1.040 | 1.030 | 1.305 | HCC70 PI103 0 1 72 |
| HCC70 | PI103 | 1 | 72 | 0.32 | 3016.5 | 3161.3 | 1279.8 | -0.495 | 0.929 | 0.954 | 1.305 | HCC70 PI103 0 1 72 |
| HCC70 | PI103 | 1 | 72 | 1.0 | 2224.3 | 3161.3 | 1279.8 | 0.0 | 0.528 | 0.704 | 1.305 | HCC70 PI103 0 1 72 |
| HCC70 | PI103 | 1 | 72 | 0.001 | 3066.0 | 3161.3 | 1279.8 | -3.0 | 0.954 | 0.970 | 1.305 | HCC70 PI103 0 1 72 |
| HCC70 | PI103 | 1 | 72 | 0.0032 | 3251.5 | 3161.3 | 1279.8 | -2.49 | 1.040 | 1.030 | 1.305 | HCC70 PI103 0 1 72 |
| HCC70 | PI103 | 1 | 72 | 0.01 | 3323.0 | 3161.3 | 1279.8 | -2.0 | 1.080 | 1.050 | 1.305 | HCC70 PI103 0 1 72 |